Brieflands
Journal finderSearch
·
Sign in

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

e-ISSN 1735-3408
p-ISSN 1735-143X
Home
Articles
    Current IssueAccepted ManuscriptsAll IssuesIn Press ArticlesSearch
Instructions
About Journal
    Journal InformationBoards and committeesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit manuscript
  1. Brieflands
  2. /
  3. journals
  4. /
  5. Hepatitis Monthly
  6. /
  7. Articles
  8. /
  9. The ITPA and C20orf194 Polymorphisms and Hematological Changes During Treatment With Pegylated-Interferon Plus Ribavirin in Patients With Chronic Hepatitis C
  10. /
  11. Scopus by Title (Ref)
Citation data

Scopus by Title (Ref)

Articles that cite the referenced work, matched by title from the Scopus database.

6 results·Updated October 19, 2026
← Back to article
1

Protective role of ITPA rs1127354-CA polymorphism against anemia in HCV patients using sofosbuvir ribavirin therapy: age and gender match case-control study

Advancements in Life Sciences

September 2023

Amjed S.

2

Inosine triphosphate pyrophosphatase polymorphisms are predictors of anemia in Chinese patients with chronic hepatitis C during therapy with ribavirin and interferon

Journal of Gastroenterology and Hepatology Australia

1 January 2020

Chi X.

3

A facile PCR-RFLP method for genotyping of ITPA rs1127354 and rs7270101 polymorphisms

Journal of Clinical Laboratory Analysis

September 2018

Alavian S.E.

Open Access

4

The role of polymorphisms near IFNL3 gene as predictors of residual HCV RNA in buffy coat after successful antiviral therapy

Hepatitis Monthly

1 April 2017

Miri S.M.

Open Access

5

A simple PCR-RFLP method for genotyping of IFNL4 rs368234815 polymorphism in patients with chronic hepatitis C

Lab Medicine

February 2017

Pouryasin M.

Open Access

6

Double therapy with pegylated interferon and ribavirin for chronic hepatitis C. A pharmacogenetic guide for predicting adverse events

Farmacia

2017

Kamal A.

Need help?

Editorial, submission and technical questions all go to the same desk.

Submit a ticket
Brieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.